 |
인쇄하기
취소
|
Hanil and Japanese Nippon Chemiphar signed business tie-up
Hanil signed an agreement with Nippon Chemiphar on June 7 for the distribution of Ozagron, a CNS drug.
President Lee Dong-il of Hanil said "we could expand the market for Ozagron in combination with injectable Herben, an angina pectoris drug. Most of all, it is very meaningful for us to have a product line for the CNS drug"
Mr. Shin-Ichiro Yamasaki, the business development and planning m...
President Lee Dong-il of Hanil said "we could expand the market for Ozagron in combination with injectable Herben, an angina pectoris drug. Most of all, it is very meaningful for us to have a product line for the CNS drug"
Mr. Shin-Ichiro Yamasaki, the business development and planning m...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.